Universal Ibogaine Inc. IBOGF

IBOGF Company Overview

Universal Ibogaine Inc. is a Canada-based life sciences company focused on addiction treatment services and research centered on ibogaine and related psychedelic-assisted therapies. The company operates in the healthcare services and mental health and addiction treatment industries, with an emphasis on medically supervised interventions for substance use disorders, including opioid and alcohol dependence. Its activities primarily involve operating treatment clinics and advancing clinical and regulatory understanding of ibogaine-based therapies.

The company’s primary revenue drivers have historically been patient treatment services delivered through affiliated or controlled clinics rather than pharmaceutical product sales. Universal Ibogaine Inc. was incorporated in Canada and became publicly listed on the TSX Venture Exchange under the ticker IBO.V. Its evolution reflects broader interest in alternative and psychedelic-assisted treatments for addiction, although ibogaine remains a controlled or restricted substance in several jurisdictions, shaping the company’s operational and geographic strategy.